Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41746-022-00627-4 http://scihub22266oqcxt.onion/10.1038/s41746-022-00627-4 35773329!9244889!35773329     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       NPJ+Digit+Med 2022 ; 5 (1): 83 Nephropedia Template TP {{tp|p=35773329|t=2022. The IDentif AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens |pdf=|usr=}}{{35773329}} gab.com Text The IDentif AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens JO: NPJ Digit Med http://www.kidney.de/pget.php?&tw=1&pmid=35773329 #FOAvip IDentif.AI-x, a clinically actionable artificial intelligence platform, was used to rapidly pinpoint and prioritize optimal combination therapies against COVID-19 by pairing a prospective, experimental validation of multi-drug efficacy on a SARS-CoV-2 live virus and Vero E6 assay with a quadratic optimization workflow. A starting pool of 12 candidate drugs developed in collaboration with a community of infectious disease clinicians was first narrowed down to a six-drug pool and then interrogated in 50 combination regimens at three dosing levels per drug, representing 729 possible combinations. IDentif.AI-x revealed EIDD-1931 to be a strong candidate upon which multiple drug combinations can be derived, and pinpointed a number of clinically actionable drug interactions, which were further reconfirmed in SARS-CoV-2 variants B.1.351 (Beta) and B.1.617.2 (Delta). IDentif.AI-x prioritized promising drug combinations for clinical translation and can be immediately adjusted and re-executed with a new pool of promising therapies in an actionable path towards rapidly optimizing combination therapy following pandemic emergence. Twit Text FOAVip The IDentif AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens ????NPJ Digit Med http://www.kidney.de/pget.php?&tw=1&pmid=35773329 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=35773329 #FOAvip English Wikipedia <ref>{{Cite pmid|35773329}}</ref> The IDentif AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens #MMPMID35773329 Blasiak A; Truong ATL; Remus A; Hooi L; Seah SGK; Wang P; Chye H; Lim APC; Ng KT; Teo ST; Tan YJ; Allen DM; Chai LYA; Chng WJ; Lin RTP; Lye DCB; Wong JE; Tan GG; Chan CEZ; Chow EK; Ho D NPJ Digit Med 2022[Jun]; 5 (1): 83 PMID35773329show ga IDentif.AI-x, a clinically actionable artificial intelligence platform, was used to rapidly pinpoint and prioritize optimal combination therapies against COVID-19 by pairing a prospective, experimental validation of multi-drug efficacy on a SARS-CoV-2 live virus and Vero E6 assay with a quadratic optimization workflow. A starting pool of 12 candidate drugs developed in collaboration with a community of infectious disease clinicians was first narrowed down to a six-drug pool and then interrogated in 50 combination regimens at three dosing levels per drug, representing 729 possible combinations. IDentif.AI-x revealed EIDD-1931 to be a strong candidate upon which multiple drug combinations can be derived, and pinpointed a number of clinically actionable drug interactions, which were further reconfirmed in SARS-CoV-2 variants B.1.351 (Beta) and B.1.617.2 (Delta). IDentif.AI-x prioritized promising drug combinations for clinical translation and can be immediately adjusted and re-executed with a new pool of promising therapies in an actionable path towards rapidly optimizing combination therapy following pandemic emergence. äThe IDentif AI-x pandemic readiness platform: Rapid prioritization of (epmc).pdf DeepDyve Pubget Overpricing